We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

115 hedge funds and large institutions have $974M invested in MyoKardia, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

444% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 9

371% more capital invested

Capital invested by funds: $207M → $974M (+$767M)

81% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 21

53% more funds holding

Funds holding: 75 → 115 (+40)

Holders
115
Holders Change
+40
Holders Change %
+53.33%
% of All Funds
2.87%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
49
Increased
38
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$34.6M
2
EC
EcoR1 Capital
California
+$22M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.6M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$18.8M
5
BlackRock
BlackRock
New York
+$17.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.1M
2
JP Morgan Chase
JP Morgan Chase
New York
-$10M
3
Millennium Management
Millennium Management
New York
-$7.12M
4
MWNA
Marshall Wace North America
New York
-$4.46M
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$2.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
76
STRS Ohio
Ohio
$745K +$555K +17,400 New
MWNA
77
Marshall Wace North America
New York
$663K -$4.46M -139,855 -90%
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$645K -$734 -23 -0.2%
Handelsbanken Fonder
79
Handelsbanken Fonder
Sweden
$643K +$479K +15,000 New
Barclays
80
Barclays
United Kingdom
$610K +$229K +7,191 +102%
PCM
81
Prelude Capital Management
New York
$593K -$353K -11,068 -44%
MLICM
82
Metropolitan Life Insurance Company (MetLife)
New York
$567K – – –
AIG
83
American International Group
New York
$546K +$64.4K +2,018 +19%
State of Wisconsin Investment Board
84
State of Wisconsin Investment Board
Wisconsin
$514K – – –
VEA
85
Virtus ETF Advisers
New York
$478K -$327K -10,245 -48%
AQR Capital Management
86
AQR Capital Management
Connecticut
$464K +$346K +10,830 New
WMSA
87
Weiss Multi-Strategy Advisers
New York
$429K +$319K +10,000 New
VOYA Investment Management
88
VOYA Investment Management
Georgia
$382K +$284K +8,909 New
DTL
89
Dynamic Technology Lab
Singapore
$369K -$347K -10,871 -56%
TD Asset Management
90
TD Asset Management
Ontario, Canada
$364K +$271K +8,500 New
CSS
91
Cubist Systematic Strategies
Connecticut
$355K +$264K +8,281 New
BCM
92
Bayesian Capital Management
New York
$311K +$232K +7,269 New
AIM
93
Alambic Investment Management
California
$283K +$211K +6,600 New
Legal & General Group
94
Legal & General Group
United Kingdom
$238K +$24.5K +767 +16%
VF
95
Virtu Financial
New York
$229K +$170K +5,342 New
SEC
96
Seven Eight Capital
New York
$223K +$166K +5,200 New
Dimensional Fund Advisors
97
Dimensional Fund Advisors
Texas
$212K +$158K +4,952 New
QT
98
Quantbot Technologies
New York
$202K +$150K +4,716 New
Bank of Montreal
99
Bank of Montreal
Ontario, Canada
$171K +$128K +4,000 New
TIM
100
Tortoise Investment Management
New York
$146K – – –
1 2 3
4
5

MYOK Hedge Fund Activity: Q3 2017 in Review

115 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2017, worth a combined $974M — up 371% from $207M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new MYOK positions and 9 closed out — a net gain of 40 holders — while 38 added to existing stakes and 21 trimmed.

The largest buyer was Deerfield Management, adding an estimated $34.6M. The largest seller was Fidelity Investments, cutting an estimated $16.1M.

  • 115 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2017, up from 75 in Q2 2017.
  • Funds reported $974M of MyoKardia, Inc. Common Stock stock for Q3 2017, up 371% quarter-over-quarter.
  • 49 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2017 and 9 closed out, a net change of +40 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q3 2017 was Deerfield Management, an estimated $34.6M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q3 2017 was Fidelity Investments, an estimated $16.1M sold.

Based on aggregated 13F filings for Q3 2017.